Cargando…

Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review

Human African trypanosomiasis (HAT), or sleeping sickness disease, is an infection caused mainly by Trypanosoma brucei gambiense-human African trypanosomiasis (g-HAT) and is transmitted by tsetse flies. The disease goes through two stages: hemolymphatic and meningo-encephalic phases. The treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hidalgo, Jessica, Ortiz, Juan Fernando, Fabara, Stephanie P, Eissa-Garcés, Ahmed, Reddy, Dinesh, Collins, Kristina D, Tirupathi, Raghavendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411996/ https://www.ncbi.nlm.nih.gov/pubmed/34513456 http://dx.doi.org/10.7759/cureus.16881

Ejemplares similares

720. Efficacy of Nifurtimox + Eflornithine in the Treatment of African Trypanosomiasis. Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda
por: Kansiime, Freddie, et al.
Publicado: (2018)

Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series
por: Checchi, Francesco, et al.
Publicado: (2007)

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole
por: Neau, Philippe, et al.
Publicado: (2020)

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program
por: Valverde Mordt, Olaf, et al.
Publicado: (2022)

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
por: Pelfrene, Eric, et al.
Publicado: (2019)

Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
por: Bernhard, Sonja, et al.
Publicado: (2022)

Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
por: Baker, Nicola, et al.
Publicado: (2011)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei
por: Vincent, Isabel M., et al.
Publicado: (2012)

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
por: Imran, Mohd, et al.
Publicado: (2022)

Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
por: Boberg, Mikael, et al.
Publicado: (2020)

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness
por: Schmid, Caecilia, et al.
Publicado: (2012)

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
por: Tarral, Antoine, et al.
Publicado: (2014)

Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
por: Kande Betu Ku Mesu, Victor, et al.
Publicado: (2021)

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
por: Kande Betu Kumesu, Victor, et al.
Publicado: (2022)

A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
por: Vincent, Isabel M., et al.
Publicado: (2010)

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo
por: Kuemmerle, Andrea, et al.
Publicado: (2020)

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
por: Kuemmerle, Andrea, et al.
Publicado: (2021)

Can Moxidectin Be an Anthelmintic Alternative for Trichuris trichiura and Strongyloides stercoralis: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2022)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Enantiospecific antitrypanosomal in vitro activity of eflornithine
por: Boberg, Mikael, et al.
Publicado: (2021)

Fexinidazole interferes with the growth and structural organization of Trypanosoma cruzi
por: Zuma, Aline Araujo, et al.
Publicado: (2022)

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
por: Watson, James A., et al.
Publicado: (2019)

The history of African trypanosomiasis
por: Steverding, Dietmar
Publicado: (2008)

Fexinidazole: A Potential New Drug Candidate for Chagas Disease
por: Bahia, Maria Terezinha, et al.
Publicado: (2012)

Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review
por: Fabara, Stephanie P, et al.
Publicado: (2021)

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
por: Villar, Juan Carlos, et al.
Publicado: (2019)

The Burden of Human African Trypanosomiasis
por: Fèvre, Eric M., et al.
Publicado: (2008)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Chemotherapy of Human African Trypanosomiasis
por: Bacchi, Cyrus J.
Publicado: (2009)

Epidemiology of human African trypanosomiasis
por: Franco, Jose R, et al.
Publicado: (2014)

Nifurtimox Inhibits the Progression of Neuroblastoma in vivo
por: Kong, Eryan, et al.
Publicado: (2019)

Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
por: Villar, Juan Carlos, et al.
Publicado: (2019)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox
por: Lang, Dieter, et al.
Publicado: (2022)

Towards the Atlas of human African trypanosomiasis
por: Cecchi, Giuliano, et al.
Publicado: (2009)

Generation of neuroinflammation in human African trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ll2o078j6se8unht2cs3b2o0qk